BASSI, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 4.620
AS - Asia 1.896
EU - Europa 1.162
AF - Africa 416
SA - Sud America 359
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 23
Totale 8.519
Nazione #
US - Stati Uniti d'America 4.411
SG - Singapore 745
CN - Cina 411
HK - Hong Kong 249
BR - Brasile 228
DE - Germania 192
FI - Finlandia 134
IT - Italia 116
VN - Vietnam 92
PL - Polonia 72
SE - Svezia 69
GB - Regno Unito 68
UA - Ucraina 62
RU - Federazione Russa 57
FR - Francia 51
NL - Olanda 44
TR - Turchia 31
AR - Argentina 26
MX - Messico 24
ID - Indonesia 22
IQ - Iraq 20
LY - Libia 19
NP - Nepal 19
PK - Pakistan 18
RS - Serbia 18
AZ - Azerbaigian 17
KE - Kenya 17
PE - Perù 17
AT - Austria 16
CA - Canada 16
CM - Camerun 16
JP - Giappone 16
PS - Palestinian Territory 16
YE - Yemen 16
ZA - Sudafrica 16
EC - Ecuador 15
ES - Italia 15
NZ - Nuova Zelanda 15
UZ - Uzbekistan 15
BF - Burkina Faso 14
CH - Svizzera 14
DJ - Gibuti 14
DO - Repubblica Dominicana 14
MA - Marocco 14
NI - Nicaragua 14
PY - Paraguay 14
EG - Egitto 13
GT - Guatemala 13
IS - Islanda 13
KH - Cambogia 13
LC - Santa Lucia 13
RW - Ruanda 13
TZ - Tanzania 13
YT - Mayotte 13
CO - Colombia 12
CU - Cuba 12
GR - Grecia 12
MN - Mongolia 12
MU - Mauritius 12
NG - Nigeria 12
SK - Slovacchia (Repubblica Slovacca) 12
AL - Albania 11
BA - Bosnia-Erzegovina 11
BJ - Benin 11
CL - Cile 11
CW - ???statistics.table.value.countryCode.CW??? 11
CZ - Repubblica Ceca 11
DK - Danimarca 11
GA - Gabon 11
GH - Ghana 11
IE - Irlanda 11
KR - Corea 11
LV - Lettonia 11
MD - Moldavia 11
NE - Niger 11
NO - Norvegia 11
TN - Tunisia 11
AM - Armenia 10
AO - Angola 10
BG - Bulgaria 10
BO - Bolivia 10
BY - Bielorussia 10
DZ - Algeria 10
ET - Etiopia 10
HN - Honduras 10
IN - India 10
JM - Giamaica 10
JO - Giordania 10
LB - Libano 10
LU - Lussemburgo 10
MK - Macedonia 10
MY - Malesia 10
PT - Portogallo 10
SA - Arabia Saudita 10
SD - Sudan 10
SN - Senegal 10
TW - Taiwan 10
VE - Venezuela 10
ZW - Zimbabwe 10
BE - Belgio 9
Totale 8.112
Città #
Fairfield 578
Woodbridge 484
Singapore 372
Chandler 344
Ann Arbor 332
Ashburn 319
Houston 270
Jacksonville 255
Hong Kong 243
Seattle 231
Cambridge 225
Wilmington 223
Beijing 115
Boardman 106
Princeton 97
Santa Clara 67
Bytom 62
Medford 61
Nanjing 61
Des Moines 54
San Diego 44
Roxbury 42
Helsinki 41
Munich 36
Ho Chi Minh City 29
Los Angeles 28
Nanchang 23
Dearborn 21
Hanoi 18
Baku 16
Shenyang 16
São Paulo 16
Tripoli 16
Padova 15
Djibouti 14
Nairobi 14
Tashkent 14
Castries 13
Guangzhou 13
Hebei 13
Jiaxing 13
Kigali 13
Managua 13
New York 13
Dar es Salaam 12
Lima 12
Phnom Penh 12
Ulan Bator 12
Buffalo 11
Chicago 11
Cotonou 11
Havana 11
Hefei 11
Jinan 11
Redwood City 11
Sanaa 11
Accra 10
Amman 10
Belgrade 10
Dakar 10
Harare 10
Niamey 10
Norwalk 10
Reykjavik 10
Rio de Janeiro 10
Vienna 10
Bishkek 9
Cairo 9
Changsha 9
Guatemala City 9
Johannesburg 9
Libreville 9
Luanda 9
Mamoudzou 9
Milan 9
Nuremberg 9
Panama City 9
Riga 9
Antananarivo 8
Auckland 8
Boston 8
Dong Ket 8
Dublin 8
Lagos 8
Lahore 8
Lusaka 8
Noumea 8
Ouagadougou 8
Rome 8
Tokyo 8
Willemstad 8
Yerevan 8
Athens 7
Dallas 7
Falls Church 7
Kampala 7
Kingstown 7
Minsk 7
Montevideo 7
Nassau 7
Totale 5.505
Nome #
Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. 226
Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. 220
Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study 213
In vivo delivery of naked antisense oligos in aged mdx mice analysis of dystrophin restoration in skeletal and cardiac muscle 205
PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis. 201
Autoinflammation and autoimmunity: Bridging the divide. 193
17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. 193
Antigen preparation for immunological studies in systemic autoimmune diseases. 189
Antigen preparation for immunological studies in systemic autoimmune diseases 175
Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. 171
The olfactory function is impaired in patients with idiopathic inflammatory myopathies. 167
Infections and autoimmunity: the multifaceted relationship. 160
Commercial blot assays in the diagnosis of systemic rheumatic diseases 158
Emerging and critical issues in the pathogenesis of lupus. 157
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay 153
Biological and clinical relevance of anti-prothrombin antibodies. 152
Serological markers in psoriatic arthritis: promising tools 152
SLE diagnosis and treatment: When early is early 152
OxLDL/β2GPI-anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients. 150
Autoantibodies in polymyositis and dermatomyositis. 145
Polymyositis, dermatomyositis and malignancy: a further intriguing link 139
Infection as triggers and complication of sistemic lupus erythematosus 138
Autoantibody testing in patients with myositis: clinical accuracy of a multi parametric line immunoassay 129
Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant. 129
Autoantibodies toward pathogenic and protective molecules in systemic lupus erythematosus: anti-oxLDL/ß2GPI and anti-PTX3 antibodies. 124
Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA) 122
Systemic delivery of therapeutic nucleic acids into skeletal muscle by means of lipid-based vectors 120
Anti-PTX3 antibody: a new antibody in lupus. 120
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus 120
Serpins, Immunity and Autoimmunity: Old Molecules, New Functions. 118
Galectin-3 in autoimmunity and autoimmune diseases 114
oxLDL/beta 2GPI complex and anti-oxLDL/beta 2GPI in SLE: Prevalence and correlates 112
DILAYED SYSTEMIC LUPUS ERYTHEMATOSUS SYMPTOMS AND INCREASED SURVIVAL BY SERPINB3 IN LUPUS-PRONE MICE 110
Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome 108
Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo 107
Pentraxins, anti-pentraxins antibodies and atherosclerosis 107
Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. 104
Aspetti clinici e immunologici associati agli anitcorpi antisintetasi in una casistica di 42 pazienti 101
null 99
Anti-MI2 antibody detection in myositis sera by chemiluminescent or chromogenic western blot assay. 97
NZB/WF1 MICE DEVELOPED ASIA SYNDROME WHEN INJECTED WITH COMPLETE FREUND'S ADJUVANT 92
Expression of regeneration markers in muscle biopsies from patients affected with autoimmune myositis. 91
Miopatia Subclinica in pazienti affetti da neoplasia del colon-retto: ipotesi sulla patogenesi delle miositi paraneoplastiche 91
Is C-reactive protein an useful tool in monitoring SLE pregnant women? 90
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus 90
IgG anti-PTX3 nel lupus eritematoso sistemico 87
Subclinical atherosclerosis in patients with psoriatic arthritis. 86
The long pentraxin 3 and its role in autoimmunity 86
Multicenter evaluation of a second-generation ELISA assay using the VCP-2 antigen for the detection of anti-citrullinated peptide antibodies 83
The role of IgG, IgM, and IgA anti-DNA isotypes in systemic lupus erythematosus 83
Predire e valutare la risposta clinica ad abatacept nei pazienti resistenti agli anti-TNF-alfa 81
Delay of nephritis in NZB/NZWF1 mice injected with pentraxin 3 78
Diagnosi precoce nel LES. 77
Serological testing in myositis patients: diagnostic accuracy of a commercial line blot assay. 77
PENTRAXINA 3 (PTX3) E FIBROSI: STUDIO IMMUNOISTOCHIMICO SU BIOPSIE RENALI IN PAZIENTI CON LES. 76
Remissione clinica, terapia e danno cumulativo nel lupus eritematoso sistemico: risultati preliminari su una coorte di 100 pazienti 76
Anti-PTX3: are they real? 75
Chronic fatigue syndrome: Characteristics and possible causes for its pathogenesis 74
Il senso dell'olfatto nella poli-dermatomiosite. 74
PATHOGENETIC AND PROTECTIVE AUTOANTIBODIES INVOLVED IN LUPUS GLOMERULONEPHRITIS 71
Antiendothelial and antineuronal cells antibodies in patients with chronic fatigue syndrome. 66
Relationship between autoantibody profile and muscle histopathological findings in inflammatory myopathies 65
Prevention of glomerulonephritis in NZB/NZWF1 mice by immunization with pentraxin 3. 65
Autoantibody detection in serum of patients with autoimmune myositis: identification of anti-SAE1/SAE2 antibodies by unlabelled protein imunoprecipitation. 65
The sense of smell in polimyositis and dermatomyositis. 65
Modulation of glomerunephritis in NZB/WF1 mice: vaccination with PTX3 induces anti-PTX3 antibodies, delays the onset and decreases the severity of glomerulonephritis 65
Livelli sierici di BLyS (B lymphocyte stimulator) in pazienti non selezionati affetti da malattie reumatiche autoimmuni 64
OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients. 64
Reduction of the olfactory function in patients with idiopathic inflammatory myopathies: a case control study. 62
Are anti-P antibodies associated with NPSLE? 62
Valutazione dell'accuratezza di un test line blot per la diagnosi sierologica di miosite autoimmune. 61
Immunization of NZB/NZWF1 mice with pentraxin 3 delays the onset and reduces the severity of glomerulonephritis. 56
Prevalence of anti-annexine XI antibodies in patients with autoimmune rheumatic diseases. 55
Modello sperimentale di nefropatia lupica: ruolo della pentraxina 3 53
NZB/WF1 mice developed ASIA syndrome when injected with complete Freund's adjuvant. 51
Immunization with PTX3 induces anti-PTX3 antibodies and delays proteinuria occurence and death in NZB/NZWF1 mice. 46
Effect of SLE pregnancy on serum cytokines. 46
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay 44
Totale 8.543
Categoria #
all - tutte 25.355
article - articoli 21.120
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021490 0 0 0 0 23 51 27 84 82 90 74 59
2021/2022768 11 107 70 86 21 26 21 93 36 10 67 220
2022/2023686 159 76 7 70 119 89 3 59 67 2 23 12
2023/2024331 17 41 43 27 30 25 28 17 11 6 33 53
2024/20251.393 6 87 73 70 190 23 53 104 117 60 271 339
2025/20262.344 179 479 717 707 262 0 0 0 0 0 0 0
Totale 8.543